CA3051244A1 - A drug monitoring tool - Google Patents

A drug monitoring tool Download PDF

Info

Publication number
CA3051244A1
CA3051244A1 CA3051244A CA3051244A CA3051244A1 CA 3051244 A1 CA3051244 A1 CA 3051244A1 CA 3051244 A CA3051244 A CA 3051244A CA 3051244 A CA3051244 A CA 3051244A CA 3051244 A1 CA3051244 A1 CA 3051244A1
Authority
CA
Canada
Prior art keywords
patient
profile
plasma protein
time
therapeutic plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3051244A
Other languages
English (en)
French (fr)
Inventor
Michael Nelson
Roman PICHLER
Gerald SPOTTS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Shire Human Genetics Therapies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Human Genetics Therapies Inc filed Critical Shire Human Genetics Therapies Inc
Publication of CA3051244A1 publication Critical patent/CA3051244A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N7/00—Computing arrangements based on specific mathematical models
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N7/00—Computing arrangements based on specific mathematical models
    • G06N7/01—Probabilistic graphical models, e.g. probabilistic networks
    • G—PHYSICS
    • G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09C—CIPHERING OR DECIPHERING APPARATUS FOR CRYPTOGRAPHIC OR OTHER PURPOSES INVOLVING THE NEED FOR SECRECY
    • G09C5/00—Ciphering apparatus or methods not provided for in the preceding groups, e.g. involving the concealment or deformation of graphic data such as designs, written or printed messages
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L9/00—Cryptographic mechanisms or cryptographic arrangements for secret or secure communications; Network security protocols
    • H04L9/06—Cryptographic mechanisms or cryptographic arrangements for secret or secure communications; Network security protocols the encryption apparatus using shift registers or memories for block-wise or stream coding, e.g. DES systems or RC4; Hash functions; Pseudorandom sequence generators
    • H04L9/0618—Block ciphers, i.e. encrypting groups of characters of a plain text message using fixed encryption transformation
    • H04L9/0637—Modes of operation, e.g. cipher block chaining [CBC], electronic codebook [ECB] or Galois/counter mode [GCM]
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/90—Programming languages; Computing architectures; Database systems; Data warehousing

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Theoretical Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Physics & Mathematics (AREA)
  • Data Mining & Analysis (AREA)
  • Primary Health Care (AREA)
  • Databases & Information Systems (AREA)
  • Computing Systems (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Software Systems (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Artificial Intelligence (AREA)
  • Evolutionary Computation (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Mathematical Optimization (AREA)
  • Mathematical Analysis (AREA)
  • Pure & Applied Mathematics (AREA)
  • Computational Mathematics (AREA)
  • Mathematical Physics (AREA)
  • Algebra (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioethics (AREA)
  • Evolutionary Biology (AREA)
CA3051244A 2017-01-27 2018-01-23 A drug monitoring tool Pending CA3051244A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762451391P 2017-01-27 2017-01-27
US62/451,391 2017-01-27
PCT/US2018/014772 WO2018140373A1 (en) 2017-01-27 2018-01-23 A drug monitoring tool

Publications (1)

Publication Number Publication Date
CA3051244A1 true CA3051244A1 (en) 2018-08-02

Family

ID=62979098

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3051244A Pending CA3051244A1 (en) 2017-01-27 2018-01-23 A drug monitoring tool

Country Status (24)

Country Link
US (2) US10896749B2 (https=)
EP (1) EP3574423B1 (https=)
JP (3) JP6860134B2 (https=)
KR (4) KR102318205B1 (https=)
CN (1) CN110383388B (https=)
AR (2) AR110909A1 (https=)
AU (1) AU2018213055B2 (https=)
BR (2) BR112019015213A8 (https=)
CA (1) CA3051244A1 (https=)
CL (1) CL2019002084A1 (https=)
CO (1) CO2019008885A2 (https=)
EA (2) EA202190788A1 (https=)
ES (1) ES2949967T3 (https=)
IL (1) IL268147B2 (https=)
MA (1) MA46492B1 (https=)
MX (1) MX2019008797A (https=)
MY (1) MY192171A (https=)
PH (1) PH12019501752A1 (https=)
PL (1) PL3574423T3 (https=)
SG (1) SG11201906837PA (https=)
TW (2) TWI806120B (https=)
UA (1) UA127734C2 (https=)
WO (1) WO2018140373A1 (https=)
ZA (3) ZA201904832B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015154090A1 (en) 2014-04-04 2015-10-08 Bloodworks Routine laboratory and point-of-care (poc) testing for hemostasis
AU2021329524A1 (en) * 2020-08-21 2023-03-16 Becton, Dickinson And Company Active patient-specific monitoring system
CN116391235A (zh) * 2020-10-06 2023-07-04 豪夫迈·罗氏有限公司 使用传感器数据生成血友病相关预测的机器学习模型
KR102428869B1 (ko) * 2020-11-23 2022-08-04 차의과학대학교 산학협력단 생리학적 약물동태학 핵심 모델
WO2022125485A1 (en) * 2020-12-11 2022-06-16 Hanger, Inc. Systems and methods for encoded clinical data communication
US12073931B2 (en) * 2022-06-15 2024-08-27 Express Scripts Strategic Development, Inc. Alternate dose regimen identification system
US12255779B2 (en) * 2022-09-14 2025-03-18 Xerox Corporation Method and apparatus to configure a multi-function device
WO2024128701A1 (ko) * 2022-12-14 2024-06-20 충남대학교산학협력단 생리학적 약동학 모델링을 이용한 한국인의 중금속 노출량 예측방법
US20250288490A1 (en) * 2024-03-14 2025-09-18 Merck Sharp & Dohme Llc System for Medicinal Supply Monitoring and Management with Controlled Packaging of Medicinal Product

Family Cites Families (167)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4709331A (en) 1984-05-01 1987-11-24 Barkett Patricia A Calculator-computer for calculating infusion rates over varying time intervals
US4810243A (en) 1985-01-18 1989-03-07 Intelligent Medicine, Inc. Device and method for effecting application of a therapeutic agent
US4807170A (en) 1986-03-25 1989-02-21 John Kulli Drug dose rate calculator
US4898578A (en) 1988-01-26 1990-02-06 Baxter International Inc. Drug infusion system with calculator
US5104374A (en) 1990-01-16 1992-04-14 Bishko Jay R Electronic fluid flow rate controller for controlling the infusion of intravenous drugs into a patient
US5723289A (en) 1990-06-11 1998-03-03 Nexstar Pharmaceuticals, Inc. Parallel selex
JP3224607B2 (ja) 1992-09-11 2001-11-05 株式会社アズウェル 血液凝固第ｘｉｉｉ因子活性測定方法および該測定用試薬キット
DE69329774T2 (de) 1992-10-15 2001-06-21 Baxter International Inc., Deerfield Infusionspumpe mit elektronisch ladbarer medikamentenbibliothek
US6330426B2 (en) 1994-05-23 2001-12-11 Stephen J. Brown System and method for remote education using a memory card
US5678571A (en) 1994-05-23 1997-10-21 Raya Systems, Inc. Method for treating medical conditions using a microprocessor-based video game
US5897493A (en) 1997-03-28 1999-04-27 Health Hero Network, Inc. Monitoring system for remotely querying individuals
US6101478A (en) 1997-04-30 2000-08-08 Health Hero Network Multi-user remote health monitoring system
US5326545A (en) 1993-03-30 1994-07-05 Valence Technology, Inc. Method of making lithium battery electrode compositions
US5833599A (en) 1993-12-13 1998-11-10 Multum Information Services Providing patient-specific drug information
US5609575A (en) 1994-04-11 1997-03-11 Graseby Medical Limited Infusion pump and method with dose-rate calculation
US5462222A (en) 1994-07-15 1995-10-31 Boeck, Ii; Edgar L. Sealing closure clip for gable top container
US5522798A (en) 1994-10-17 1996-06-04 Abbott Laboratories Control of a multi-channel drug infusion pump using a pharmacokinetic model
US5792833A (en) 1994-12-22 1998-08-11 New England Medical Center Hospitals, Inc. E2 binding proteins
EP0737926A1 (en) 1995-04-11 1996-10-16 Hoechst Marion Roussel, Inc. Method for determining pharmacodynamic parameters and designing a dosing regimen for a drug
US6321164B1 (en) 1995-06-07 2001-11-20 Akzo Nobel N.V. Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US5630664A (en) 1995-12-20 1997-05-20 Farrelly; Patricia A. Hand held apparatus for performing medical calculations
DK0796623T3 (da) 1996-03-20 2005-08-01 Baxter Ag Farmaceutisk præparat til behandling af blodkoagulationslidelser
US5915971A (en) 1996-07-29 1999-06-29 Chemical Concepts Corporation Tutorial device and method for determining drug dosages
EP1005376B1 (en) 1997-03-14 2010-11-03 The Children's Hospital of Philadelphia Compositions for use in gene therapy for treatment of hemophilia
US6025984A (en) 1997-09-22 2000-02-15 Borkowski; Brian Portable drug information computer
DE19755682A1 (de) 1997-12-15 1999-06-17 Knoll Ag Verfahren zur Ermittlung eines Dosierungschemas für Thrombininhibitoren
US20020010595A1 (en) 1998-02-27 2002-01-24 Kapp Thomas L. Web-based medication management system
AU2673599A (en) 1998-02-27 1999-09-15 Thomas L. Kapp Pharmacy drug management system providing patient specific drug dosing, drug interaction analysis, order generation, and patient data matching
US6421650B1 (en) 1998-03-04 2002-07-16 Goetech Llc Medication monitoring system and apparatus
US7820796B2 (en) 1998-03-12 2010-10-26 Genetics Institute, Llc. Methods for producing Factor VIII proteins
US6167412A (en) 1998-07-14 2000-12-26 Agilent Technologies, Inc. Handheld medical calculator and medical reference device
US20010041964A1 (en) * 1998-09-14 2001-11-15 George M. Grass Pharmacokinetic-based drug design tool and method
BR9804648A (pt) 1998-11-23 2000-05-30 Fundacao Oswaldo Cruz Monitorização da obediência do paciente ao tratamento e da biodisponibilidade de drogas pela desproteinização de fluidos corpóreos.
US6358703B1 (en) 1998-12-10 2002-03-19 Bayer Corporation Expression system for factor VIII
WO2000067776A1 (en) 1999-05-11 2000-11-16 Ortho-Mcneil Pharmaceuticals, Inc. Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
US8326649B2 (en) 1999-11-18 2012-12-04 Koninklijke Philips Electronics N.V. System for providing expert care to outpatients from a remote location
US6658396B1 (en) 1999-11-29 2003-12-02 Tang Sharon S Neural network drug dosage estimation
US7693697B2 (en) 1999-12-07 2010-04-06 University Of Utah Research Foundation Anesthesia drug monitor
US7860583B2 (en) 2004-08-25 2010-12-28 Carefusion 303, Inc. System and method for dynamically adjusting patient therapy
AU1227302A (en) 2000-09-15 2002-03-26 Virco Nv System and method for optimizing drug therapy for the treatment of diseases
WO2002032036A2 (en) 2000-10-10 2002-04-18 University Of Utah Research Foundation Method and apparatus for monitoring anesthesia drug dosages, concentrations, and effects using n-dimensional representations of critical functions
US20050054942A1 (en) 2002-01-22 2005-03-10 Melker Richard J. System and method for therapeutic drug monitoring
US7043415B1 (en) 2001-01-31 2006-05-09 Pharsight Corporation Interactive graphical environment for drug model generation
US20020130779A1 (en) 2001-03-13 2002-09-19 Herbert Ford Intensive care calculator
WO2002073503A2 (en) 2001-03-14 2002-09-19 Baxter International Inc. Internet based therapy management system
US7015193B2 (en) 2001-04-20 2006-03-21 University Of Vermont Compositions and methods to control bleeding
US6844149B2 (en) 2001-06-29 2005-01-18 International Business Machines Corporation Method, system, and apparatus for measurement and recording of blood chemistry and other physiological measurements
GB0116142D0 (en) 2001-07-02 2001-08-22 Astrazeneca Ab Method
EP1418976B1 (en) 2001-07-31 2013-06-26 Scott Laboratories, Inc. Apparatuses and methods for titrating drug delivery
WO2003019332A2 (en) 2001-08-27 2003-03-06 Informmed Handheld medication dosage calculator
US20030078760A1 (en) 2001-10-19 2003-04-24 Globomax Holdings, Llc Population pharmacokinetic modeling and analysis (PDx-POP™)
US6944638B1 (en) 2001-11-14 2005-09-13 Katharine T. Putnam Medication dosage calculator
US7204823B2 (en) 2001-12-19 2007-04-17 Medtronic Minimed, Inc. Medication delivery system and monitor
US20070167853A1 (en) 2002-01-22 2007-07-19 Melker Richard J System and method for monitoring health using exhaled breath
WO2003079149A2 (en) 2002-03-11 2003-09-25 The University Of Vermont And State Agriculture College Blood clotting predictor
MXPA04009343A (es) 2002-03-28 2005-01-25 Abbott Lab Sistema y metodo para manejar un programa de tratamiento de pacientes.
US20100205001A1 (en) 2002-05-15 2010-08-12 Novo Nordisk A/S System and method for assisting in the home treatment of a medical condition
US20060129357A1 (en) 2002-08-27 2006-06-15 Francis Mathis, Inc., D/B/A Informmed Medication dose calculator
US20080052317A1 (en) 2002-08-27 2008-02-28 Francis Katharine R Medication dose calculator and associated methods
US9740817B1 (en) 2002-10-18 2017-08-22 Dennis Sunga Fernandez Apparatus for biological sensing and alerting of pharmaco-genomic mutation
TW200422917A (en) 2003-02-01 2004-11-01 Baxter Int Wireless medical data communication system and method
US6956572B2 (en) * 2003-02-10 2005-10-18 Siemens Medical Solutions Health Services Corporation Patient medical parameter user interface system
US9342657B2 (en) 2003-03-24 2016-05-17 Nien-Chih Wei Methods for predicting an individual's clinical treatment outcome from sampling a group of patient's biological profiles
EP1617799A2 (en) 2003-04-09 2006-01-25 Wyeth Hemophilia treatment by inhalation of coagulation factors
PL2298347T3 (pl) 2003-05-06 2016-03-31 Bioverativ Therapeutics Inc Białka chimeryczne czynnika krzepnięcia do leczenia zaburzenia hemostazy
KR20060040676A (ko) 2003-07-11 2006-05-10 미리어드 제네틱스, 인크. 알츠하이머병을 치료하기 위한 약제학적 방법, 투약 방법및 제형
US8200775B2 (en) 2005-02-01 2012-06-12 Newsilike Media Group, Inc Enhanced syndication
WO2005038049A2 (en) 2003-10-06 2005-04-28 Heinrich Guenther System and method for optimizing drug therapy
SE0302815D0 (sv) 2003-10-24 2003-10-24 Mathcore Engineering Ab Computer system for determining a drug dosage
US8532730B2 (en) 2006-10-04 2013-09-10 Dexcom, Inc. Analyte sensor
DE102004010516A1 (de) 2004-03-04 2005-09-22 Bayer Technology Services Gmbh Verbessertes Verfahren zur zeitlichen Dosierung von Arzneistoffen
US7813880B2 (en) 2004-03-25 2010-10-12 University Of Maryland, Baltimore Apparatus and method for providing optimal concentrations for medication infusions
EP1642607A1 (en) 2004-10-04 2006-04-05 Sanofi-Aventis Deutschland GmbH Dose display mechanism for a drug delivery device
US20060078897A1 (en) 2004-10-13 2006-04-13 Wedinger Robert S Method of providing customized drug delivery correlating to a patient's metabolic profile
EP1812101A4 (en) 2004-11-16 2014-04-23 Medrad Inc MODELING PHARMACEUTICAL DISSIPATION
JP2006155071A (ja) 2004-11-26 2006-06-15 Toshiba Sumiden Medical Information Systems Corp 電子カルテ薬物療法指示実施システム
US20080040151A1 (en) 2005-02-01 2008-02-14 Moore James F Uses of managed health care data
SG158906A1 (en) * 2005-02-11 2010-02-26 Cardinal Health 303 Inc Identification system and method for medication management
US20060271405A1 (en) 2005-05-27 2006-11-30 Regents Of The University Of Minnesota Pharmaceutical care of patients and documentation system therefor
JP2009517186A (ja) 2005-11-29 2009-04-30 チルドレンズ ホスピタル メディカル センター 薬物選択及び投薬の最適化及び個別化
US7875288B2 (en) 2006-03-30 2011-01-25 The Research Foundation Of State University Of New York Method for treating blood coagulation disorders
US8380539B2 (en) 2006-05-09 2013-02-19 University Of Louisville Research Foundation, Inc. Personalized medicine management software
US7990251B1 (en) 2006-05-17 2011-08-02 Ford Jr Herbert Drug management systems
DE102006028232A1 (de) 2006-06-20 2007-12-27 Bayer Technology Services Gmbh Vorrichtung und Verfahren zur Berechnung und Bereitstellung einer Medikamentendosis
WO2008009459A1 (en) 2006-07-21 2008-01-24 Novartis Ag Pharmacokinetic modelling of mycophenolic acid
US20080091083A1 (en) 2006-10-12 2008-04-17 Yudkovitch Laurence M Anesthetic drug model user interface
US20080091084A1 (en) 2006-10-12 2008-04-17 Yudkovitch Laurence M User interface for a pk/pd anesthetic drug model display
US8326545B2 (en) 2006-10-18 2012-12-04 General Electric Company System and method for displaying a pharmacokinetic and pharmacodynamic drug model
US7997269B2 (en) 2006-10-18 2011-08-16 General Electric Company System and method of safely displaying PK/PD anesthetic drug models
US20100143326A1 (en) 2007-01-03 2010-06-10 Novo Nordisk Healthcare A/G SUBCUTANEOUS ADMINISTRATION OF COAGULATION FACTOR VIIa-RELATED POLYPEPTIDES
US8099298B2 (en) 2007-02-14 2012-01-17 Genelex, Inc Genetic data analysis and database tools
US9398863B2 (en) 2007-06-20 2016-07-26 General Electric Company Detection of anomalies in measurement of level of hypnosis
KR101183854B1 (ko) 2007-06-27 2012-09-20 에프. 호프만-라 로슈 아게 테라피 시스템용 환자 정보 입력 인터페이스
EP2562664B1 (en) 2007-06-27 2020-11-25 Roche Diabetes Care GmbH System for determining an insulin delivery and communicating a dose in automated pancreas software
WO2009010948A1 (en) 2007-07-18 2009-01-22 Famillion Ltd. Method and system for use of a database of personal data records
WO2010100649A1 (en) 2009-03-04 2010-09-10 Sensible Medical Innovations Ltd. Methods and systems for monitoring intrabody tissues
US8560337B2 (en) 2007-09-28 2013-10-15 Cerner Innovation, Inc. User interface for generating and managing medication tapers
WO2009049276A1 (en) 2007-10-12 2009-04-16 Patientslikeme, Inc. Personalized management and monitoring of medical conditions
US20090144082A1 (en) 2007-11-30 2009-06-04 Steven Selbst Physician practice management software for maximizing reimbursement rates from payer contracts
WO2009102808A2 (en) 2008-02-12 2009-08-20 Tosk, Incorporated Doxorubicin adjuvants to reduce toxicity and methods for using the same
WO2009111465A2 (en) 2008-03-03 2009-09-11 Virginia Commonwealth University Comprehensive modeling of the highly networked coagulation-fibrinolysis-inflammatory-immune system
WO2009120991A2 (en) 2008-03-27 2009-10-01 Medtronic, Inc. Pharmacokinetic and pharmacodynamic tools to define patient specific therapeutic regimens
US9649469B2 (en) 2008-04-24 2017-05-16 The Invention Science Fund I Llc Methods and systems for presenting a combination treatment
US8682687B2 (en) 2008-04-24 2014-03-25 The Invention Science Fund I, Llc Methods and systems for presenting a combination treatment
US20100036676A1 (en) 2008-08-07 2010-02-11 E-Merge Health Solutions, Ltd. Computer implemented medical treatment management system
WO2010020423A2 (en) 2008-08-22 2010-02-25 Baxter Healthcare S.A. Methods for treating bleeding disorders
WO2010048532A1 (en) 2008-10-24 2010-04-29 Amicus Therapeutics, Inc. Multiple compartment dosing model
US8591454B2 (en) 2008-11-10 2013-11-26 The Invention Science Fund I, Llc Administering a therapeutic agent with more than one taggant
US9727139B2 (en) 2008-12-12 2017-08-08 Immersion Corporation Method and apparatus for providing a haptic monitoring system using multiple sensors
US20100152620A1 (en) 2008-12-12 2010-06-17 Immersion Corporation Method and Apparatus for Providing A Haptic Monitoring System Using Multiple Sensors
US20100169063A1 (en) 2008-12-31 2010-07-01 The General Electric Company System and Method of Modeling the Pharmacodynamic Effect to Drugs Delivered to a Patient
US8046242B1 (en) 2009-01-22 2011-10-25 Mckesson Financial Holdings Limited Systems and methods for verifying prescription dosages
WO2010096191A2 (en) * 2009-02-18 2010-08-26 Exbiblio B.V. Automatically capturing information, such as capturing information using a document-aware device
GB2480965B (en) 2009-03-25 2014-10-08 Proteus Digital Health Inc Probablistic pharmacokinetic and pharmacodynamic modeling
US20100273738A1 (en) 2009-04-23 2010-10-28 Valcke Christian P Integrated patient management and control system for medication delivery
EP2427841B1 (en) * 2009-05-05 2019-08-14 CareFusion 303, Inc. Model-based infusion site monitor
US8412538B2 (en) 2009-06-09 2013-04-02 Wellpartner Incorporated System and method for prepurchased replenishment of pharmaceuticals
EP2443620B1 (en) 2009-06-16 2018-09-05 SimQuest LLC Hemorrhage control simulator
US20110015939A1 (en) 2009-07-17 2011-01-20 Marcos Lara Gonzalez Systems and methods to create log entries and share a patient log using open-ended electronic messaging and artificial intelligence
WO2011014721A2 (en) 2009-07-30 2011-02-03 Transposagen Biopharmaceuticals, Inc. Genetically modified rat models for pharmacokinetics
US8370056B2 (en) 2009-08-12 2013-02-05 Ford Global Technologies, Llc False event suppression for collision avoidance systems
EP2525702A4 (en) 2009-09-28 2014-10-29 Illuminare Holdings Ltd DEVICE AND NETWORK FOR INTRAVAGINAL MONITORING
SI2506868T1 (en) * 2009-12-06 2018-04-30 Bioverativ Therapeutics Inc. HYPER AND HYBRID POLYPETTIDES FACTOR VIII-FC AND METHODS FOR THEIR USE
US20110195488A1 (en) 2010-02-10 2011-08-11 Selinfreund Richard H Devices for collection and stabilization of biomarkers in liquid samples
EP2371284A1 (en) 2010-03-24 2011-10-05 C A Casyso AG Method and apparatus for determining at least one evaluation parameter of a blood sample
NZ602382A (en) * 2010-03-26 2014-11-28 Abraxis Bioscience Llc Methods of treatment of hepatocellular carcinoma
CN103189504B (zh) 2010-06-18 2017-05-24 北卡罗莱纳州立大学 减少炎性反应的具有减少的脂磷壁酸的重组乳杆菌
PL3552619T3 (pl) 2010-07-09 2025-12-01 Bioverativ Therapeutics Inc. Polipeptydy czynnika ix i sposoby ich zastosowania
US9603860B2 (en) 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US9950112B2 (en) 2010-08-17 2018-04-24 University Of Florida Research Foundation, Incorporated Intelligent drug and/or fluid delivery system to optimizing medical treatment or therapy using pharmacodynamic and/or pharamacokinetic data
EP2632479B1 (en) 2010-10-27 2017-06-14 Baxalta GmbH Fviii peptides for immune tolerance induction and immunodiagnostics
US8589186B1 (en) 2010-11-01 2013-11-19 Walgreen Co. Systems and methods for determining pharmaceutical consultation compliance
US20120150748A1 (en) * 2010-12-14 2012-06-14 Xtreme Mobility Inc. System and method for authenticating transactions through a mobile device
US9596237B2 (en) * 2010-12-14 2017-03-14 Salt Technology, Inc. System and method for initiating transactions on a mobile device
WO2012079576A1 (en) 2010-12-16 2012-06-21 Region Nordjylland Methods and models for predicting dosage of a drug and/or response in an individual
DK2685898T3 (da) 2011-03-18 2022-11-28 Sanofi Aventis Deutschland Beregning af en medikamentdosis
WO2012160161A1 (en) 2011-05-25 2012-11-29 Sanofi-Aventis Deutschland Gmbh Handheld medicament delivery device with dose button
AU2012262322B2 (en) 2011-05-30 2016-11-03 Autotelic Llc Methods and compositions for therapeutic drug monitoring and dosing by point-of-care pharmacokinetic profiling
DK3412305T3 (da) 2011-06-10 2021-03-01 Baxalta GmbH Behandling af koagulationssygdom ved administration af rekombinant vwf
EP2538360A1 (en) 2011-06-16 2012-12-26 Koninklijke Philips Electronics N.V. Method of predicting a blood dilution risk value
MX344792B (es) * 2011-09-25 2017-01-06 Theranos Inc Sistemas y métodos para múltiples análisis.
WO2013049624A1 (en) 2011-09-30 2013-04-04 University Of Louisville Research Foundation, Inc. System and method for personalized dosing of pharmacologic agents
US20130085712A1 (en) 2011-09-30 2013-04-04 Industrial Technology Research Institute Inertial sensing input apparatus and method thereof
US9500639B2 (en) 2012-07-18 2016-11-22 Theranos, Inc. Low-volume coagulation assay
US10001495B2 (en) 2012-07-25 2018-06-19 Bioverativ Therapeutics Inc. Blood factor monitoring assay and uses thereof
US8744828B2 (en) 2012-07-26 2014-06-03 Rimidi Diabetes, Inc. Computer-implemented system and method for improving glucose management through modeling of circadian profiles
SG10201907682RA (en) 2012-10-05 2019-10-30 Mould Diane System and method for providing patient-specific dosing as a function of mathematical models
HK1213767A1 (zh) 2012-10-18 2016-07-15 Bioverativ Therapeutics Inc. 使用固定劑量凝血因子的方法
US20140114676A1 (en) * 2012-10-23 2014-04-24 Theranos, Inc. Drug Monitoring and Regulation Systems and Methods
HK1214539A1 (zh) 2012-10-30 2016-07-29 Bioverativ Therapeutics Inc. 應用viii因子多肽的方法
US20140142979A1 (en) * 2012-11-21 2014-05-22 Tracy Mitsunaga Medical Quick Response Codes and Information Storage and Retrieval System
CN110504035B (zh) 2013-01-16 2023-05-30 梅达器材 医疗资料库及系统
WO2014121257A1 (en) * 2013-02-04 2014-08-07 Sano Informed Prescribing, Llc Prescription decision support system and method using comprehensive multiplex drug monitoring
US20160033523A1 (en) 2013-02-16 2016-02-04 Novozymes Biopharma Dk A/S Pharmacokinetic animal model
US8961479B2 (en) 2013-03-19 2015-02-24 Biolife, L.L.C. Hemostatic device and method
US20140303901A1 (en) 2013-04-08 2014-10-09 Ilan Sadeh Method and system for predicting a disease
SG11201510515YA (en) 2013-06-20 2016-01-28 Baxalta Inc Providing a pharmacokinetic drug dosing regime
ES2725611T3 (es) 2013-08-20 2019-09-25 Baxalta Inc Dispositivo para fomentar el cumplimiento del programa de medicación y las técnicas de administración adecuadas
US10325687B2 (en) 2013-12-06 2019-06-18 Bioverativ Therapeutics Inc. Population pharmacokinetics tools and uses thereof
FR3016461B1 (fr) 2014-01-10 2017-06-23 Imabiotech Procede de traitement de donnees d'imagerie moleculaire et serveur de donnees correspondant
US10755217B2 (en) * 2014-04-05 2020-08-25 Wearable Intelligence, Inc. Systems and methods for digital workflow and communication
TWI528217B (zh) * 2014-07-02 2016-04-01 柯呈翰 於線上加上即時檔案動態標籤、加密之系統及方法
US10534895B2 (en) 2015-01-20 2020-01-14 Icpd Technologies, Llc System and method for ranking options for medical treatments
NZ762158A (en) * 2015-03-03 2022-05-27 Wonderhealth Llc Access control for encrypted data in machine-readable identifiers
SG10201506662XA (en) * 2015-03-03 2016-10-28 Mastercard Asia Pacific Pte Ltd Method For Enabling A Communication Link Between A Mobile Terminal And A Receiving Terminal
CA2988724C (en) 2015-04-09 2023-10-10 Diane R. Mould Systems and methods for patient-specific dosing
CA3020346A1 (en) 2016-04-15 2017-10-19 Baxalta Incorporated Method and apparatus for providing a pharmacokinetic drug dosing regimen

Also Published As

Publication number Publication date
IL268147B1 (en) 2024-02-01
EA202190788A1 (ru) 2021-10-29
PL3574423T3 (pl) 2023-09-11
EA037986B1 (ru) 2021-06-21
JP2021108135A (ja) 2021-07-29
EP3574423A1 (en) 2019-12-04
JP6860134B2 (ja) 2021-04-14
MX2019008797A (es) 2019-09-11
WO2018140373A1 (en) 2018-08-02
CL2019002084A1 (es) 2020-05-08
EP3574423A4 (en) 2020-10-14
KR20190109477A (ko) 2019-09-25
AU2018213055B2 (en) 2022-09-08
BR122021000189A2 (https=) 2020-04-14
KR102233784B1 (ko) 2021-03-29
TWI806120B (zh) 2023-06-21
JP2020510899A (ja) 2020-04-09
MA46492A1 (fr) 2019-11-29
CN110383388A (zh) 2019-10-25
KR102414958B1 (ko) 2022-07-01
SG11201906837PA (en) 2019-08-27
AU2018213055A1 (en) 2019-08-15
MA46492B1 (fr) 2020-04-30
UA127734C2 (uk) 2023-12-20
CN110383388B (zh) 2024-02-20
PH12019501752A1 (en) 2019-09-16
US20210098103A1 (en) 2021-04-01
IL268147B2 (en) 2024-06-01
JP7107627B2 (ja) 2022-07-27
KR20210088750A (ko) 2021-07-14
BR112019015213A8 (pt) 2023-03-28
BR122021000189A8 (pt) 2023-03-28
ES2949967T3 (es) 2023-10-04
KR20210130258A (ko) 2021-10-29
TW201837923A (zh) 2018-10-16
EA201991778A1 (ru) 2019-12-30
MY192171A (en) 2022-08-04
US11783931B2 (en) 2023-10-10
ZA201904832B (en) 2020-12-23
JP7416869B2 (ja) 2024-01-17
KR102277321B1 (ko) 2021-07-13
TWI738961B (zh) 2021-09-11
EP3574423B1 (en) 2023-04-19
JP2022137191A (ja) 2022-09-21
US10896749B2 (en) 2021-01-19
ZA202004405B (en) 2022-03-30
CO2019008885A2 (es) 2020-01-17
US20180218782A1 (en) 2018-08-02
AR125645A2 (es) 2023-08-02
BR112019015213A2 (pt) 2020-04-14
TW202145245A (zh) 2021-12-01
IL268147A (en) 2019-09-26
KR102318205B1 (ko) 2021-10-26
AR110909A1 (es) 2019-05-15
ZA202105060B (en) 2023-01-25
KR20210034689A (ko) 2021-03-30

Similar Documents

Publication Publication Date Title
US11783931B2 (en) Drug monitoring tool
Perfetti Reusable and disposable insulin pens for the treatment of diabetes: understanding the global differences in user preference and an evaluation of inpatient insulin pen use
Cangialosi Management of a maxillary central incisor impacted by a supernumerary tooth
HK40016993A (en) A drug monitoring tool
Green et al. Oral melanoma: report of case
HK40016993B (zh) 药物监测工具
EA042521B1 (ru) Инструмент для мониторирования лекарственного средства
Spoors et al. Discrete choice experiments: An overview of experience to date in haemophilia
Servin et al. Real-world utilization and initial experience with aflibercept-ayyh (PAVBLU®) for retinal disorders in United States retina practices: A descriptive retrospective analysis
Basu et al. Exploring the potential of a smartphone application (“FreshStart”) for tobacco cessation: A feasibility and acceptability study from India
Waldman et al. The ‘busyness’ problem
Whelton et al. Use of dental service data to inform research and policy
Krishnan In search of research conducted at the highest levels……
Lee et al. Limited evidence that cantilevers are associated with slightly lower survival rates of implant-supported fixed partial dentures
Glaros et al. ASSESSING BRUXISM: Authors' response

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220922

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 7TH ANNIV.) - STANDARD

Year of fee payment: 7

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241223

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241223

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241223

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20250113

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20250506

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250506

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20250721

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20250721